Burns Matteson Capital Management LLC Acquires New Shares in Tenet Healthcare Corporation $THC

Burns Matteson Capital Management LLC bought a new stake in shares of Tenet Healthcare Corporation (NYSE:THC) during the 4th quarter, HoldingsChannel reports. The firm bought 3,810 shares of the company’s stock, valued at approximately $757,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Boston Partners increased its holdings in Tenet Healthcare by 38.8% in the 3rd quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after buying an additional 880,413 shares in the last quarter. Ameriprise Financial Inc. lifted its stake in Tenet Healthcare by 8.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after acquiring an additional 157,109 shares during the period. AQR Capital Management LLC boosted its holdings in shares of Tenet Healthcare by 62.3% during the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after acquiring an additional 720,160 shares during the last quarter. Norges Bank bought a new stake in shares of Tenet Healthcare in the second quarter worth approximately $206,981,000. Finally, Eminence Capital LP purchased a new position in shares of Tenet Healthcare during the third quarter valued at approximately $225,263,000. 95.44% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have commented on THC. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a research report on Thursday, February 12th. Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Sunday, March 1st. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a report on Wednesday, March 4th. Morgan Stanley reissued an “overweight” rating and issued a $260.00 target price on shares of Tenet Healthcare in a report on Thursday, February 12th. Finally, Royal Bank Of Canada boosted their price target on Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a research note on Thursday, February 12th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $250.56.

Insiders Place Their Bets

In related news, insider R. Scott Ramsey sold 8,017 shares of Tenet Healthcare stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total transaction of $1,865,555.90. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Paola M. Arbour sold 6,500 shares of the stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the sale, the executive vice president owned 29,291 shares of the company’s stock, valued at $6,983,853.13. The trade was a 18.16% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 46,517 shares of company stock worth $10,943,111. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Trading Up 0.3%

NYSE:THC opened at $188.56 on Wednesday. The firm has a market capitalization of $16.40 billion, a price-to-earnings ratio of 12.17, a price-to-earnings-growth ratio of 0.91 and a beta of 1.39. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The business has a fifty day moving average price of $213.53 and a 200-day moving average price of $205.21. Tenet Healthcare Corporation has a one year low of $109.82 and a one year high of $247.21.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same quarter in the previous year, the company posted $3.44 earnings per share. Tenet Healthcare’s revenue for the quarter was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Sell-side analysts forecast that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.